JCP
ALXN

Jabre Capital Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Jabre Capital Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
2018
Q2 		$1.55M Sell
2018
Q1 		$3.34M Sell
2017
Q4 		$4.19M Buy
2013
Q4 		– Sell
2013
Q3 		$12.1M Buy